Axios Re:Cap

Latest Episodes:

Opioids in the pandemic Aug 18, 2020

Show notes

Prior to the pandemic, America’s most urgent public health crisis was the opioid epidemic. It’s been overshadowed by the coronavirus, but meanwhile the situation may have gotten much worse. Dan is joined by the Associated Press's Geoff Mulvihill to discuss this situation and the next phase of litigation against prescription opioid makers.

Rep. Carolyn Maloney on fixing the U.S. Postal Service Aug 17, 2020

Show notes

Within the next week, House Democrats plan to vote on $25 billion in new funding for the U.S. Postal Service and to hold an Oversight Committee hearing at which Postmaster General Louis DeJoy is expected to testify. Dan is joined by Oversight Committee chair Rep. Carolyn Maloney (D-N.Y.) to discuss the future of USPS and how it will impact this November's election.

Back to school 2020: The loss of learning Aug 15, 2020

Show notes

This weekend we're posting four mini-episodes of the Axios Re:Cap podcast, focused on the unique challenges of back-to-school in 2020. This one digs into learning loss, and its long-term implications for students, schools, and the economy.

Back to school 2020: The device drought Aug 15, 2020

Show notes

This weekend we're posting four mini-episodes of the Axios Re:Cap podcast, focused on the unique challenges of back-to-school in 2020. This one digs into the device drought that could render remote learning irrelevant.

Back to school 2020: The rise of learning pods Aug 15, 2020

Show notes

This weekend we're posting four mini-episodes of the Axios Re:Cap podcast, focused on the unique challenges of back-to-school in 2020. This one digs into learning pods, including what they are, how schools are reacting, and the inequities they may exacerbate.

Back to school 2020: Special ed under pressure Aug 15, 2020

Show notes

This weekend we're posting four mini-episodes of the Axios Re:Cap podcast, focused on the unique challenges of back-to-school in 2020. This one digs into the strains on special education.

Glass Animals’ Dave Bayley on releasing an album into a pandemic Aug 14, 2020

Show notes

This year has been devastating for the live music industry, especially for touring musicians, some of whom earn up to 90% of their income from playing live. Axios Re:Cap producer Naomi Shavin is joined by Glass Animals frontman Dave Bayley, who released an album this week and discusses what it’s like to release and promote music when touring isn’t an option.

The pandemic reality for Black women founders Aug 13, 2020

Show notes

The U.S. for months has faced a national reckoning over simultaneous crises that Black Americans, especially, are facing: structural racism and violence, health disparities in COVID-19 outcomes and devastating economic impacts from the pandemic. Axios Re:Cap producer Naomi Shavin is joined by Shelly Bell, founder of Black Girl Ventures, to discuss how the founders in her network are faring, what happened after her organization received a wave of donations in June, and what she hopes to see happen next.

The fight over the future of ridesharing Aug 12, 2020

Show notes

On Monday, a California Superior Court judge ruled that Uber and Lyft should classify drivers as employees, not temporary contractors. Both companies plan to appeal, and on Wednesday, Uber’s CEO said that if this ruling is upheld, the company would have to temporarily stop operating in California. The ruling has implications far beyond the ridesharing industry, for the entire gig economy and more. Axios Re:Cap producer Naomi Shavin discusses the ruling and what comes next with Mike Isaac of the New York Times and author of “Super Pumped: The Battle for Uber.”

Russia’s vaccine gamble Aug 11, 2020

Show notes

Russia announced Tuesday that it has approved a vaccine for COVID-19 and has plans to inoculate health care workers, teachers, and others in the coming months, despite barely starting Phase 3 clinical trials. Axios Re:Cap producer Naomi Shavin digs into the impacts of this announcement on the vaccine race with Derek Lowe, medicinal chemist, author and expert on drug development and the pharmaceutical industry.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

Axios Re:Cap

Related Podcasts

1

2

3

4

5

6